Richard P. Blumberg - Feb 23, 2023 Form 4 Insider Report for GUIDED THERAPEUTICS INC (GTHP)

Role: Director, 10%+ Owner
Signature: /s/ Richard P. Blumberg
Stock symbol: GTHP
Transactions as of: Feb 23, 2023
Transactions value $: $0
Form type: 4
Date filed: 6/27/2023, 12:02 PM
Previous filing: Jun 27, 2023
Next filing: Sep 20, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	GTHP	Common stock	Other		+400K	+18.96%		2.51M	Mar 1, 2023	Direct	F1
transaction	GTHP	Common stock	Exercise of in-the-money or at-the-money derivative security		+831K	+33.12%		3.34M	Mar 15, 2023	Direct	F2
transaction	GTHP	Common stock	Other		+77K	+2.3%		3.42M	Mar 31, 2023	Direct	F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	GTHP	Warrants	Other		-875K	-32.41%		1.83M	Feb 15, 2023	Common shares	875K	$0.25	Direct	F2
transaction	GTHP	Warrants	Other		+831K			831K	Feb 22, 2023	Common shares	831K	$0.20	Direct	F2
transaction	GTHP	Warrants	Exercise of in-the-money or at-the-money derivative security		-831K	-100%		0	Feb 22, 2023	Common shares	831K	$0.20	Direct	F2
transaction	GTHP	Warrants	Other		+900K			900K	Mar 1, 2023	Common Shares	900K	$0.30	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	On March 10, 2021, the Company entered into a consulting agreement with Richard Blumberg, which was subsequently amended during the year ended December 31, 2021. As a result of the consulting agreement Mr. Blumberg provided $350,000 to the Company in exchange for 1,600,000 common shares and 3,600,000 warrants to acquire common shares with an exercise price of $0.30. Issuance of the common stock and warrants was predicated on the Company obtaining financing totaling a minimum of $1.0 million and Mr. Blumberg's continued service for the Company. The common stock and warrants are required to be issued in four equal tranches, the first of which was issued on March 1, 2023 and was due 6 months after the Company obtained the requisite financing. The remaining tranches are due in six-month installments until the final tranche is issued in September 2024.
F2	During February 2023, Mr. Blumberg signed an exchange agreement to exchange 875,000 warrants to purchase shares of common stock for an exercise price of $0.25, for 831,250 warrants to purchase shares of common stock for an exercise price of $0.20. The newly exchanged warrants were subsequently exercised upon payment of $166,250.
F3	These shares were issued for payment of accrued dividends on the reporting individual's Series F and Series F-2 preferred stock, at a conversion price of $0.2712.